Sunnyvale, California, October 21, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) today announced that it will release its third quarter 2026 financial results after the close of U.S. markets on Wednesday, November 4, 2026.
Following the earnings release, the company’s management will hold a webcast and conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results and business developments.
Q3 2026 Webinar and Conference Call Details
The live stream link and replay will be posted on the relevant page of the GRAIL Investor Relations website at investors.grail.com.
Register for the live event at the following URL: https://grail-q3-financial-results-2026.open-exchange.net/
To ensure timely access, please complete registration and join the webcast at least 10 minutes before the conference call begins. The live stream and recorded replay are open to all interested parties.
About GRAIL
Grail is a healthcare company dedicated to detecting cancer early, when it is curable. The company is committed to reducing the global burden of cancer by leveraging next-generation sequencing, large-scale clinical studies, and advanced machine learning, software, and automation technologies to detect and identify multiple deadly cancer types at earlier stages.
GRAIL’s targeted methylation platform supports the entire care pathway for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker profiling, and treatment and recurrence monitoring.
GRAIL is headquartered in Sunnyvale, California, with offices in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.